Intrinsic Value of S&P & Nasdaq Contact Us

Erasca, Inc. ERAS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
48/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.60
-35%

Erasca, Inc. (ERAS) has 12 identified peers for comparison in the Healthcare sector. Peers include ARVN, BDTX, CCCC, CGEM, DSGN, EWTX and others.

ERAS has a market capitalization of $5.55B, compared to an average peer market cap of $916.66M. ERAS is significantly larger than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message